• About
• Links
• Contact
• Sitemap
• 

Prostate Cancer - Drug Pipeline Analysis and Market Forecasts to 2015

Summary

The report is an essential source of information and analysis on the global prostate cancer market. The report identifies the key trends shaping and driving the global prostate cancer market, a key segment within the pharma industry. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global prostate cancer sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by team of industry experts.

Scope

The scope of the report includes:

Annualized global prostate cancer market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.

Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.

Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.

Analysis of the current and future market competition in the global prostate cancer market. Key market players covered include Sanofi-aventis, Pfizer Inc., AstraZeneca, Bristol-Myers Squibb and GlaxoSmithKline plc.

Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with prostate cancer.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

Develop business strategies by understanding the trends shaping and driving the global prostate cancer market.

Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global prostate cancer market in future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

What’s the next big thing in the global prostate cancer market landscape? – Identify, understand and capitalize.

Table of Contents

1 Table of contents 3

• 1.1 List of Tables 5
• 1.2 List of Figures 5

2 Prostate Cancer: Market Characterization 6

• 2.1 Overview 6
  • 2.1.1 Symptoms 6
  • 2.1.2 Treatment 6
  • 2.1.3 Epidemiology 7
• 2.2 Prostate Cancer Market Size 7
• 2.3 Prostate Cancer Market Forecast and CAGR 7
• 2.4 Drivers and Barriers for Prostate Cancer Market 8
  • 2.4.1 Drivers for Prostate Cancer Market 9
  • 2.4.2 Barriers for Prostate Cancer Market 9
• 2.5 Opportunity and Unmet Need 9
• 2.6 Key Takeaway 11

3 Prostate Cancer Market: Competitive Assessment 12

• 3.1 Overview 12
• 3.2 Strategic Competitor Assessment 12
• 3.3 Product Profile for the Major Marketed Products in the Prostate Cancer Market 12
  • 3.3.1 Taxotere (docetaxel) 12
  • 3.3.2 Eligard (leuprolide acetate) 13
  • 3.3.3 Trelstar (triptorelin) 14
  • 3.3.4 Firmagon (degarelix) 15
• 3.4 Key Takeaway 16
• 3.5 Major Marketed Products Comparison in Prostate Cancer Market 17

4 Prostate Cancer Market: Pipeline Assessment 18

• 4.1 Overview 18
• 4.2 Strategic Pipeline Assessment 18
  • 4.2.1 Technology Trends Analytic Framework 18
• 4.3 Prostate Cancer Therapeutics – Promising Drugs Under Clinical Development 19
• 4.4 Molecule Profile for Promising Drugs under Clinical Development 20
  • 4.4.1 Provenge (sipuleucel-T) 20
  • 4.4.2 Denosumab 21
  • 4.4.3 Aflibercept (VEGF Trap) 22
  • 4.4.4 Ipilimumab 23
  • 4.4.5 Abiraterone Acetate (CB7630) 23
• 4.5 Prostate Cancer Therapeutics Market – Clinical Pipeline by Therapeutic Class 24
• 4.6 Prostate Cancer Disease Pipeline – Pipeline by Clinical Phases of Development 25
  • 4.6.1 Prostate Cancer Therapeutics – Phase III and Regulatory Filed Clinical Pipeline 26
  • 4.6.2 Prostate Cancer Therapeutics – Phase II Clinical Pipeline 28
  • 4.6.3 Prostate Cancer Therapeutics – Phase I Clinical Pipeline 34
  • 4.6.4 Prostate Cancer Therapeutics – Preclinical Pipeline 36
  • 4.6.5 Prostate Cancer Therapeutics – Drug Discovery Pipeline 36
• 4.7 Key Takeaway 37

5 Global Prostate Cancer Market: Implications for Future Market Competition 38

• 5.1 Strategic Competitor Assessment 39

6 Global Prostate Cancer Market: Future Players in Prostate Cancer Market 40

• 6.1 Introduction 40
• 6.2 Sanofi-aventis 40
  • 6.2.1 Company Overview 40
  • 6.2.2 Business Description 41
• 6.3 Pfizer Inc. 44
  • 6.3.1 Company Overview 44
  • 6.3.2 Business Description 45
• 6.4 AstraZeneca 47
  • 6.4.1 Company Overview 47
  • 6.4.2 Business Description 48
• 6.5 Bristol-Myers Squibb 50
  • 6.5.1 Company Overview 50
  • 6.5.2 Business Description 50
• 6.6 GlaxoSmithKline plc. 51
  • 6.6.1 Company Overview 51
  • 6.6.2 Business Description 52

7 Global Prostate Cancer Market: Appendix 55

• 7.1 Definitions 55
• 7.2 Acronyms 55
• 7.3 Research Methodology 55
  • 7.3.1 Coverage 56
  • 7.3.2 Secondary Research 56
  • 7.3.3 Forecasting 57
  • 7.3.4 Primary Research 60
  • 7.3.5 Expert Panels 60
• 7.4 Contact Us 60
• 7.5 Disclaimer 60
• 7.6 Sources 62

1.1 List of Tables

• Table 1: Prostate Cancer Therapeutics Market, Global, Cancer Categorized by Disease Stage, 2009 6
• Table 2: Global Prostate Cancer Therapeutics Market, Historic Revenue ($m), 2000-2008 8
• Table 3: Global Prostate Cancer Therapeutics Market, Revenue Forecasts ($ m), 2009-2015 8
• Table 4: Major Marketed Products Comparison in Prostate Cancer Market, 2009 17
• Table 5: Prostate Cancer Therapeutics – Most Promising Drugs Under Clinical Development, 2009 19
• Table 6: Prostate Cancer Therapeutics – Phase III and Regulatory Filed Clinical Pipeline, 2009 26
• Table 7: Prostate Cancer Therapeutics – Phase II Clinical Pipeline, 2009 28
• Table 8: Prostate Cancer Therapeutics – Phase I Clinical Pipeline, 2009 34
• Table 9: Prostate Cancer Therapeutics – Preclinical Pipeline, 2009 36
• Table 10: Prostate Cancer Therapeutics – Drug Discovery Pipeline, 2009 36
• Table 11: Sanofi-aventis – Oncology Pipeline Products, 2009 43
• Table 12: Sanofi-aventis – Prostate Cancer Pipeline Products, 2009 44
• Table 13: Pfizer Inc – Oncology Pipeline Products, 2009 46
• Table 14: Pfizer Inc – Prostate Cancer Pipeline Products, 2009 47
• Table 15: AstraZeneca – Oncology Pipeline Products, 2009 49
• Table 16: AstraZeneca – Prostate Cancer Pipeline Products, 2009 50
• Table 17: Bristol-Myers Squibb Company – Oncology Pipeline Products, 2009 51
• Table 18: Bristol-Myers Squibb Company – Prostate Cancer Pipeline Products, 2009 51
• Table 19: GlaxoSmithKline plc – Oncology Pipeline Products, 2009 54
• Table 20: GlaxoSmithKline plc – Prostate Cancer Pipeline Products, 2009 54

1.2 List of Figures

• Figure 1: Global Prostate Cancer Therapeutics Market Forecasts ($m), 2000–2015 8
• Figure 2: Prostate Cancer Therapeutics Market – Opportunity and Unmet Need, 2009 10
• Figure 3: Prostate Cancer Therapeutics Market – Strategic Competitor Assessment, 2009 12
• Figure 4: Technology Trends Analytic Framework of the Prostate Cancer Pipeline, 2009 18
• Figure 5: Technology Trends Analytic Framework of the Prostate Cancer Pipeline – Description, 2009 19
• Figure 6: Prostate Cancer Therapeutics Market – Clinical Pipeline by Mechanism Of Action, 2009 24
• Figure 7: Prostate Cancer Pipeline by Phase of Clinical Development, 2009 25
• Figure 8: Prostate Cancer Therapeutics Market – Strategic Competitor Assessment, 2009 39
• Figure 9: Prostate Cancer Therapeutics Market – Clinical Pipeline by Company, 2009 40
• Figure 10: Methodology 56
• Figure 11: Market Forecasting Model 59

Other users found this report page using the following search terms: prostate cancer cancer prostate market pipeline drug drugs 2015 analysis size forecasts

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.

Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.